ACM

Aquilo Capital Management Portfolio holdings

AUM $37.1M
This Quarter Return
-0.91%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
AUM
$88.8M
AUM Growth
+$88.8M
Cap. Flow
-$10.3M
Cap. Flow %
-11.59%
Top 10 Hldgs %
89.35%
Holding
14
New
Increased
5
Reduced
5
Closed
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ARWR icon
1
Arrowhead Research
ARWR
$3.05B
$15.4M 11.69%
795,813
-112,661
-12% -$2.18M
BPMC
2
DELISTED
Blueprint Medicines
BPMC
$11.5M 8.74%
124,600
+10,000
+9% +$925K
KYMR icon
3
Kymera Therapeutics
KYMR
$2.95B
$9.88M 7.49%
208,743
-120,000
-37% -$5.68M
RGNX icon
4
Regenxbio
RGNX
$451M
$9.76M 7.4%
930,708
+24,460
+3% +$257K
ARVN icon
5
Arvinas
ARVN
$568M
$9.58M 7.26%
388,766
-40,000
-9% -$985K
MRUS icon
6
Merus
MRUS
$4.98B
$5.89M 4.46%
117,855
-30,254
-20% -$1.51M
SLN
7
Silence Therapeutics
SLN
$227M
$5.77M 4.37%
317,214
-183,000
-37% -$3.33M
BCYC
8
Bicycle Therapeutics
BCYC
$511M
$4.12M 3.12%
181,911
+25,219
+16% +$571K
IMTX icon
9
Immatics
IMTX
$619M
$3.81M 2.89%
333,502
+133,502
+67% +$1.52M
ACET icon
10
Adicet Bio
ACET
$59.9M
$3.64M 2.76%
2,531,194
DTIL icon
11
Precision BioSciences
DTIL
$57.8M
$3.42M 2.59%
381,803
RPTX icon
12
Repare Therapeutics
RPTX
$71.7M
$3.4M 2.58%
989,364
+32,432
+3% +$112K
STRO icon
13
Sutro Biopharma
STRO
$72.7M
$2.64M 2%
762,498
SPY icon
14
SPDR S&P 500 ETF Trust
SPY
$658B
0